- Home
- CYRX vs JBGS Comparison
CYRX vs JBGS Comparison
Compare CYRX & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | JBGS |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.3M | 823.7M |
| IPO Year | 2008 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CYRX | JBGS |
|---|---|---|
| Price | $17.83 | $11.39 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 9 | 3 |
| Target Price | ★ $19.78 | $12.00 |
| AVG Volume (30 Days) | 638.0K | ★ 853.8K |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 6.54% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $176,177,000.00 | ★ $498,598,000.00 |
| Revenue This Year | $10.96 | N/A |
| Revenue Next Year | $10.10 | $2.56 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.61 | $9.93 |
| 52 Week High | $18.67 | $21.86 |
Technical Indicators
Market Signals| Indicator | CYRX | JBGS |
|---|---|---|
| Relative Strength Index (RSI) | 57.25 | 55.95 |
| Support Level | $14.55 | $10.91 |
| Resistance Level | $18.17 | $11.55 |
| Average True Range (ATR) | 0.74 | 0.35 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 65.76 | 90.87 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.